BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14756145)

  • 1. Basaloid cell carcinoma of the prostate.
    Mastropasqua MG; Pruneri G; Renne G; De Cobelli O; Viale G
    Virchows Arch; 2003 Dec; 443(6):787-91. PubMed ID: 14756145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal cell proliferations of the prostate other than usual basal cell hyperplasia: a clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification.
    McKenney JK; Amin MB; Srigley JR; Jimenez RE; Ro JY; Grignon DJ; Young RH
    Am J Surg Pathol; 2004 Oct; 28(10):1289-98. PubMed ID: 15371944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal cell carcinoma of the prostate: a clinicopathologic study of 29 cases.
    Ali TZ; Epstein JI
    Am J Surg Pathol; 2007 May; 31(5):697-705. PubMed ID: 17460452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basaloid carcinoma of the prostate: an extremely rare tumor.
    Rodriguez-Carlin A; Arellano L; López-Fontana G; Bolufer E; Castillo OA
    Arch Esp Urol; 2013 May; 66(4):380-4. PubMed ID: 23676544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basaloid carcinoma of the prostate: a case report and review of the literature.
    Hudson E; Rashid M; Carter AC; Lester JF
    Eur J Cancer Care (Engl); 2008 Sep; 17(5):509-11. PubMed ID: 18616505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer with aberrant diffuse p63 expression: report of a case and review of the literature and morphologic mimics.
    Wu A; Kunju LP
    Arch Pathol Lab Med; 2013 Sep; 137(9):1179-84. PubMed ID: 23991727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal neuroendocrine differentiation in prostatic gland carcinoma with basaloid pattern.
    Gligorijević JV; Velicković LV; Jancić SA; Radovanović Z; Krstić MS; Katić VV
    Vojnosanit Pregl; 2011 Jun; 68(6):515-8. PubMed ID: 21818920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
    Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
    Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
    Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal cell carcinoma of the prostate: unusual subtype of prostatic carcinoma.
    Komura K; Inamoto T; Tsuji M; Ibuki N; Koyama K; Ubai T; Azuma H; Katsuoka Y
    Int J Clin Oncol; 2010 Dec; 15(6):594-600. PubMed ID: 20422244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoid cystic/basal cell carcinoma of the prostate: clinicopathologic findings in 19 cases.
    Iczkowski KA; Ferguson KL; Grier DD; Hossain D; Banerjee SS; McNeal JE; Bostwick DG
    Am J Surg Pathol; 2003 Dec; 27(12):1523-9. PubMed ID: 14657711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.
    Zhou M; Shah R; Shen R; Rubin MA
    Am J Surg Pathol; 2003 Mar; 27(3):365-71. PubMed ID: 12604893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody.
    Oliai BR; Kahane H; Epstein JI
    Am J Surg Pathol; 2002 Sep; 26(9):1151-60. PubMed ID: 12218571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal cell carcinoma of the prostate: a case report.
    Stearns G; Cheng JS; Shapiro O; Nsouli I
    Urology; 2012 Jun; 79(6):e79-80. PubMed ID: 22656427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous tumour-like, atypical basal cell hyperplasia and acinar adenocarcinoma of the prostate: a comparative morphological and genetic approach.
    Luebke AM; Schlomm T; Gunawan B; Bonkhoff H; Füzesi L; Erbersdobler A
    Virchows Arch; 2005 Mar; 446(3):338-41. PubMed ID: 15726402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer.
    Yang XJ; Lecksell K; Gaudin P; Epstein JI
    Am J Surg Pathol; 1999 Feb; 23(2):147-52. PubMed ID: 9989840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal cell carcinoma of the prostate: clinicopathologic analysis of three cases and a review of the literature.
    Chang K; Dai B; Kong Y; Qu Y; Wu J; Ye D; Yao X; Zhang S; Zhang H; Zhu Y; Yao W
    World J Surg Oncol; 2013 Aug; 11(1):193. PubMed ID: 23941693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basaloid adenocarcinoma. A new variant of pulmonary adenocarcinoma.
    Marci V; Volante M; Cappia S; Righi L; Novello C; Scagliotti GV; Brambilla E; Papotti M
    Virchows Arch; 2007 Sep; 451(3):729-36. PubMed ID: 17618455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathologic characteristics of basal cell carcinoma of the prostate: analysis of 5 cases and review of the literature].
    Wang Y; Guo P; Liu QS; Xie XC; Gu CY; Jing M; Liu GP
    Zhonghua Nan Ke Xue; 2014 Feb; 20(2):160-4. PubMed ID: 24520670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.